Referentielijst

Abbas SQ (2004)
Abbas SQ. Use of thioridazine in palliative care patients with troublesome sweating. J Pain Symptom Manage. 2004 Mar;27(3):194-5.

Ahimahalle TZ (2012)
Ahimahalle TZ, Ahmadi AS, ASrabi M, Rahmani L. Clincial comparison of the effect of gabapentin and megestrol acetate on hot flashes in patients with breast cancer. Int J Hemat Oncol Stem Cell Res 2012;6:7-10.

Bajaj V (2007)
Bajaj V, Langtry JAA. Use of oral glycopyrronium bromide in hyperhydrosis.Br J Dermatol 2007;157:118-21.

Barton DL (1998)
Barton DL, Loprinzi CL, Quella SK, Sloan JA, Veeder MH, Egner JR, Fidler P, Stella PJ, Swan DK, Vaught NL, Novotny P. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol. 1998 Feb;16(2):495-500.

Baumgartner FJ (2020)
Baumgartner FJ. BMJ Best Practice: Hyperhidrosis. 2020. Beschikbaar op: https://bestpractice.bmj.com/topics/en-us/856. [Bezocht op 30 mei 2021].

Bertelli G (2002)
Bertelli G, Venturini M, Del Mastro L, Bergaglio M, Sismondi P, Biglia N, Venturini S, Porcile G, Pronzato P, Costantini M, Rosso R. Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study. Ann Oncol. 2002 Jun;13(6):883-8.

Biglia N (2009)
Biglia N, Sgandurra P, Peano E, Marenco D, Moggio G, Bounous V, Tomasi Cont N, Ponzone R, Sismondi P. Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs. vitamin E. Climacteric. 2009 Aug;12(4):310-8.

Boekhout AH (2011)
Boekhout AH, Vincent AD, Dalesio OB, van den Bosch J, Foekema-Töns JH, Adriaansz S, Sprangers S, Nuijen B, Beijnen JH, Schellens JH. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2011 Oct 10;29(29):3862-8.

Bordeleau L (2010)
Bordeleau L, Pritchard KI, Loprinzi CL, Ennis M, Jugovic O, Warr D, Haq R, Goodwin PJ. Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. J Clin Oncol. 2010 Dec 10;28(35):5147-52.

Buijs C (2009)
Buijs C, Mom CH, Willemse PH, Marike Boezen H, Maurer JM, Wymenga AN, de Jong RS, Nieboer P, de Vries EG, Mourits MJ. Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study. Breast Cancer Res Treat. 2009 Jun;115(3):573-80.

Calder K (2000)
Calder K, Bruera E. Thalidomide for night sweats in patients with advanced cancer. Palliat Med. 2000 Jan;14(1):77-8.

Calfisch C (2003)
Calfisch C, Figner B, Eich D. Biperiden for excessive sweating form methadone. Am J Psych 2003;160(2):386.

Canaday BR (1995)
Canaday BR, Stanford RH. Propantheline bromide in the management of hyperhidrosis associated with spinal cord injury. Ann Pharmacoth 1995;29:489-92.

Carpenter JS (2007)
Carpenter JS, Storniolo AM, Johns S, Monahan PO, Azzouz F, Elam JL, Johnson CS, Shelton RC. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. Oncologist. 2007 Jan;12(1):124-35.

Cowap J (1998)
Cowap J, Hardy J. Thioridazine in the management of cancer-related sweating. J Pain Symptom Manage. 1998 May;15(5):266.

De Jongh E (2017)
De Jongh E, Verduijn MM. NHG-behandelrichtlijn hyperhidrose. 2017. Beschikbaar op: https://richtlijnen.nhg.org/behandelrichtlijnen/hyperhidrose#volledige-tekst. [Bezocht op 30 mei 2021].

Deaner PB (1998)
Deaner PB. Thalidomide for distressing night sweats in advanced malignant disease. Palliat Med 1998;12:208-9.

Deaner PB (2000)
Deaner PB. The use of thalidomide in the management of severe sweating in patients with advanced malignancy: trial report. Palliat Med. 2000;14(5):429-31.

Del Boz J (2020)
Del Boz J, García-Souto F, Rivas-Ruiz F, Polo-Padillo J. Survival study of treatment adherence by patients given oral glycopyrrolate for hyperhidrosis following treatment failure with oral oxybutynin. Dermatol Ther. 2020 Nov;33(6):e14210.

Deng G (2007)
Deng G, Vickers A, Yeung S, D'Andrea GM, Xiao H, Heerdt AS, Sugarman S, Troso-Sandoval T, Seidman AD, Hudis CA, Cassileth B. Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients. J Clin Oncol. 2007 Dec 10;25(35):5584-90.

Fortuin D (2017)
Fortuin D. Zweten. In: van Wanrooij B.S., In ’t Veld C.J., van Venrooij M.H, van Heest F.B. Palliatieve zorg in de huisartspraktijk. Nederlands Huisarts Genootschap: 2017.

Frisk J (2008)
Frisk J, Carlhäll S, Källström AC, Lindh-Astrand L, Malmström A, Hammar M. Long-term follow-up of acupuncture and hormone therapy on hot flushes in women with breast cancer: a prospective, randomized, controlled multicenter trial. Climacteric. 2008 Apr;11(2):166-74.

Gerber GS (2000)
Gerber GS, Zagaja GP, Ray PS, Rukstalis DB. Transdermal estrogen in the treatment of hot flushes in men with prostate cancer. Urology. 2000 Jan;55(1):97-101.

Goldberg (1994)
Goldberg, R.M., et al., Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. Journal of Clinical Oncology, 1994;12(1):155-8.

Goodwin JW (2008)
Goodwin JW, Green SJ, Moinpour CM, Bearden JD 3rd, Giguere JK, Jiang CS, Lippman SM, Martino S, Albain KS. Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. J Clin Oncol. 2008 Apr 1;26(10):1650-6.

Guirguis M (2015)
Guirguis M, Abdelmalak J, Jusino E, Hansen MR, Girgis GE. Stellate Ganglion Block for the Treatment of Hot Flashes in Patients with Breast Cancer: A Literature Review. Ochsner J. 2015;15(2):162-9.

Guttuso T Jr (2013)
Guttuso T Jr. Stellate ganglion block for treating hot flashes: a viable treatment option or sham procedure? Maturitas. 2013 Nov;76(3):221-4.

Hami F (1994)
Hami F, Trotman I. The treatment of sweating. Eur J Palliat Care 1994;6:184-187.

Hervik (2009)
Hervik, J. and O. Mjaland, Acupuncture for the treatment of hot flashes in breast cancer patients, a randomized, controlled trial. Breast Cancer Research & Treatment. 2009;116(2):311-6.

Hofland J (2019)
Hofland J, Herrera-Martínez AD, Zandee WT, de Herder WW. Management of carcinoid syndrome: a systematic review and meta-analysis. Endocr Relat Cancer. 2019 Mar;26(3):R145-R156.

IKNL (2008)
IKNL. Richtlijn ‘Koorts’, versie 2.0. 2008. Beschikbaar op: https://www.pallialine.nl/koorts [Bezocht op 18 mei 2021].

IKNL (2011)
IKNL. Handreiking ‘Palliatieve zorg aan mensen met een niet-westerse achtergrond’. 2011. Beschikbaar op: https://www.pallialine.nl/index.php?pagina=/richtlijn/item/pagina.php&id=34562&richtlijn_id=824 [Bezocht op 3 mei 2021].

IKNL/Palliactief (2017)
IKNL/Palliactief. Kwaliteitskader palliatieve zorg Nederland. 2017. Beschikbaar op: https://palliaweb.nl/publicaties/kwaliteitskader-palliatieve-zorg-nederland-public [Bezocht op 3 mei 2021].

Irani (2010)
Irani, J., et al., Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial. Lancet Oncology. 2010;11(2):147-54.

Kenemans P (2009)
Kenemans P, Bundred NJ, Foidart JM, Kubista E, von Schoultz B, Sismondi P, Vassilopoulou-Sellin R, Yip CH, Egberts J, Mol-Arts M, Mulder R, van Os S, Beckmann MW; LIBERATE Study Group. Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncol. 2009 Feb;10(2):135-46.

Kimmick (2006)
Kimmick, G.G., et al., Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen. Breast Journal. 2006;12(2):114-22.

Kroiss R (2005)
Kroiss R, Fentiman IS, Helmond FA, Rymer J, Foidart JM, Bundred N, Mol-Arts M, Kubista E. The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial. BJOG. 2005 Feb;112(2):228-33.

Leon-Ferre RA (2019)
Leon-Ferre RA, Novotny PJ, Wolfe EG, Faubion SS, Ruddy KJ, Flora D, Dakhil CSR, Rowland KM, Graham ML, Le-Lindqwister N, Smith TJ, Loprinzi CL. Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603). JNCI Cancer Spectr. 2019 Oct 21;4(1):pkz088.

Lesi (2016)
Lesi, G., et al., Acupuncture As an Integrative Approach for the Treatment of Hot Flashes in Women With Breast Cancer: A Prospective Multicenter Randomized Controlled Trial (AcCliMaT). Journal of Clinical Oncology. 2016;34(15):1795-802.

Li T (2019)
Li T, Yang J, Lv Y, Yin F, Xu L, Liu H, Zheng Q, Li L. Quantitative comparison of drug efficacy in treating hot flashes in patients with breast cancer. Breast Cancer Res Treat. 2019 Feb;173(3):511-520.

Liljegren (2012)
Liljegren, A., et al., Reducing vasomotor symptoms with acupuncture in breast cancer patients treated with adjuvant tamoxifen: a randomized controlled trial. Breast Cancer Research & Treatment. 2012;135(3):791-8.

Loibl S (2007)
Loibl S, Schwedler K, von Minckwitz G, Strohmeier R, Mehta KM, Kaufmann M. Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study. Ann Oncol. 2007 Apr;18(4):689-93.

Loprinzi CL (1994-1)
Loprinzi CL, Michalak JC, Quella SK, O'Fallon JR, Hatfield AK, Nelimark RA, Dose AM, Fischer T, Johnson C, Klatt NE, et al. Megestrol acetate for the prevention of hot flashes. N Engl J Med. 1994-1 Aug 11;331(6):347-52.

Loprinzi CL (1994-2)
Loprinzi CL, Goldberg RM, O'Fallon JR, Quella SK, Miser AW, Mynderse LA, Brown LD, Tschetter LK, Wilwerding MB, Dose M, et al. Transdermal clonidine for ameliorating post-orchiectomy hot flashes. J Urol. 1994-2 Mar;151(3):634-6.

Loprinzi CL (2000)
Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, LaVasseur BI, Barton DL, Novotny PJ, Dakhil SR, Rodger K, Rummans TA, Christensen BJ. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet. 2000 Dec 16;356(9247):2059-63.

Loprinzi CL (2002)
Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, Halyard MY, Pruthi S, Novotny PJ, Rummans TA. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol. 2002 Mar 15;20(6):1578-83.

Loprinzi CL (2009)
Loprinzi, CL, et al., A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB). Annals of Oncology. 2009;20(3):542-549.

Maida V (2008)
Maida V. Nabilone for the treatment of paraneoplastic night sweats: a report of four cases. J Palliat Med. 2008 Jul;11(6):929-34.

Maillard H (2011)
Maillard H, Fenot M, Bara C, Célérier P. Therapeutic value of moderate-dose oxybutynin in extensive hyperhidrosis. Ann Dermatol Venereol 2011;138(10):652-6.

Mao JJ (2015)
Mao JJ, Bowman MA, Xie SX, Bruner D, DeMichele A, Farrar JT. Electroacupuncture Versus Gabapentin for Hot Flashes Among Breast Cancer Survivors: A Randomized Placebo-Controlled Trial. J Clin Oncol. 2015 Nov 1;33(31):3615-20.

Mercadante S (1998)
Mercadante S. Hyoscine in opioid-induced sweating. Journal of Pain and Symptom Management 1998;15(4):214–215.

Millán-Cayetano JF (2017)
Millán-Cayetano JF, Boz J del, Rivas-Ruiz F, Blázquez-Sánchez N, Ibáñez CH, Troya-Martín de M. Oral oxybutynin for the treatment of hyperhidrosis: outcomes after one-year follow-up. Australas J Dermatol 2017;58(2):e31-e35.

Mold JW (2012)
Mold JW, Holtzclaw BJ, McCarthy L. Night sweats: a systematic review of the literature. J Am Board Fam Med. 2012 Nov-Dec; 25(6): 878-93.

Nawrocki S (2019)
Nawrocki S, Cha J. The etiology, diagnosis, and management of hyperhidrosis: A comprehensive review: Etiology and clinical work-up. J Am Acad Dermatol. 2019 Sep;81(3):657-666.

Nedstrand E (2005)
Nedstrand E, Wijma K, Wyon Y, Hammar M. Vasomotor symptoms decrease in women with breast cancer randomized to treatment with applied relaxation or electro-acupuncture: a preliminary study. Climacteric. 2005 Sep;8(3):243-50.

NHS Scotland (2019)
NHS Scotland. Scottish Palliative Care Guidelines: Sweating. 2019. Beschikbaar op: https://www.palliativecareguidelines.scot.nhs.uk/guidelines/symptom-control/sweating.aspx. [Bezocht op 30 mei 2021].

Othman AH (2014)
Othman AH, Zaky AH. Management of hot flushes in breast cancer survivors: comparison between stellate ganglion block and pregabalin. Pain Med. 2014 Mar;15(3):410-7.

Pandya KJ (2000)
Pandya, K.J., et al., Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study. Annals of Internal Medicine. 2000;132(10):788-93.

Pandya KJ (2005)
Pandya KJ, Morrow GR, Roscoe JA, Zhao H, Hickok JT, Pajon E, Sweeney TJ, Banerjee TK, Flynn PJ. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet. 2005 Sep 3-9;366(9488):818-24.

Perera E (2013)
Perera E, Sinclair R. Hyperhidrosis and bromhidrosis, a guide to asssessment and management. Australian Fam Physician 2013; 42: 266-269.

Pharos (2017)
Pharos. Lessen uit gesprekken over leven en dood. 2017. Beschikbaar op: https://www.pharos.nl/kennisbank/lessen-uit-gesprekken-over-leven-en-dood/ [Bezocht op 3 mei 2021].

Porzio G (2006)
Porzio G, Aielli F, Verna L, Porto C, Aloisi P, Cannita K, Ricevuto, E, Marchetti P, Ficorelle C. Gabapentin in the treatment of severe sweating experienced by advanced cancer patients. Supp Care Cancer 2006;14:389-91.

Quigley CS (1997)
Quigley CS, Baines M. Descriptive epidemiology of sweating in a hospice population. J Palliat Care. 1997; 13(1): 22-6.

Rahimzadeh P (2018)
Rahimzadeh P, Imani F, Nafissi N, Ebrahimi B, Faiz SHR. Comparison of the effects of stellate ganglion block and paroxetine on hot flashes and sleep disturbance in breast cancer survivors. Cancer Manag Res. 2018 Oct 26;10:4831-4837. 

Ram R (2007)
Ram R, Lowe NJ, Yamauchi PS. Current and emerging therapeutic modalities for hyperhidrosis, part 1: conservative and noninvasive treatments. Cutis. 2007 Mar;79(3):211-7.

Ramaswami R (2015)
Ramaswami R, Villarreal MD, Pitta DM, Carpenter JS, Stebbing J, Kalesan B. Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2015 Jul;152(2):231-7.

Regnard C (1996)
Regnard C. Use of low-dose thioridazine to control sweating in advanced cancer. Palliat Med 1996;10: 78 –9.

Richardson C (2001)
Richardson C, Kelly DL, Conley RR. Biperiden for excessive sweating. Am J Psych 2001;158(8):1329-30.

Russell N (2018)
Russell, N., et al., Short-term effects of transdermal estradiol in men undergoing androgen deprivation therapy for prostate cancer: a randomized placebo-controlled trial. European Journal of Endocrinology. 2018;178(5):565-576.

Schollhammer M (2015)
Schollhammer M, Brenaut E, Menard-Andivot N, Pillette-Delarue M, Zagnoli A, Chassain-Le Lay M, Sassolas B, Jouan N, Le Ru Y, Abasq-Thomas C, Greco M, Penven K, Roguedas-Contios AM, Dupré-Goetghebeur D, Gouedard C, Misery L, Le Gal G. Oxybutynin as a treatment for generalized hyperhidrosis: a randomized, placebo-controlled trial. Br J Dermatol. 2015 Nov;173(5):1163-8.

Solish N (2008)
Solish N, Wang R, Murray CA. Evaluating the patient presenting with hyperhidrosis. Thorac Surg Clin. 2008 May;18(2):133-140.

Stearns V (2005)
Stearns V, Slack R, Greep N, Henry-Tilman R, Osborne M, Bunnell C, Ullmer L, Gallagher A, Cullen J, Gehan E, Hayes DF, Isaacs C. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol. 2005 Oct 1;23(28):6919-30.

Su CW (2007)
Su CW, Gaskie S, Hitchcock K, Johnson L. Clinical inquiries. What's the best diagnostic evaluation of night sweats? J Fam Pract. 2007 Jun;56(6):493-5.

Toldeo-Pastrana T (2017)
Toldeo-Pastrana T, Márquez-Enríquez J, Millán-Cayetano JF. Estudio multicéntrico sobre el uso de oxibutinina oral en hiperhidrosis local y multifocal (Oral oxybutunin for local and multifocal hyperhidrosis: a multicenter study). Acts Dermosifiliogr 2017;108:597-9.

Try C (2012)
Try C, Messikh R, Elkhyat A, Aubin F, Humbert RP. Use of oral oxybutynin at 7.5 mg per day in primary hyperhidrosis. Rev Med Liege 2012;67(10):520-6.

Tupker RA (2006)
Tupker RA, Harmsze AM, Deneer VHM. Oxybutynin therapy for generalized hyperhidrosis. Arch Dermatol 2006;142:1065-6.

Viera AJ (2003)
Viera AJ, Bond MM, Yates SW. Diagnosing night sweats. Am Fam Physician. 2003 Mar 1;67(5):1019-24.

Vitolins MZ (2013)
Vitolins, M.Z., et al., Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer. Journal of Clinical Oncology. 2013;31(32):4092-8.

Walega DR (2014)
Walega DR, Rubin LH, Banuvar S, Shulman LP, Maki PM. Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clinical trial in postmenopausal women. Menopause. 2014 Aug;21(8):807-14.

Walker EM (2010)
Walker EM, Rodriguez AI, Kohn B, Ball RM, Pegg J, Pocock JR, Nunez R, Peterson E, Jakary S, Levine RA. Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial. J Clin Oncol. 2010 Feb 1;28(4):634-40.

Walling HW (2011)
Walling HW, Swick BL. Treatment options for hyperhidrosis. Am J Clin Dermatol. 2011 Oct 1;12(5):285-95.

Walling HW (2012)
Walling HW. Systemic therapy for primary hyperhidrosis: a retrospective study of 59 patients treated with glycopyrrolate or clonidine. J Am Acad Dermatol. 2012;66(3):387-92.

Wolosker N (2020)
Wolosker N, Kauffman P, Campos, JRM de, Faustino CB, Silva, MFA da, Teivelis MP, Puech-Leão P. Long-term results pf the treatment of primary hyperhidrosis with oxybutynin: follow op 1,658 cases. Int J Dermatol 2020;59:709-15.

Wu MF (2009)
Wu MF, Hilsenbeck SG, Tham YL, Kramer R, Elledge RM, Chang JC, Friedman LC. The efficacy of sertraline for controlling hot flashes in women with or at high risk of developing breast cancer. Breast Cancer Res Treat. 2009 Nov;118(2):369-75.

Yuanqing P (2020)
Yuanqing P, Yong T, Haiqian L, Gen C, Shen X, Dong J, Qi C, Miaomiao Q. Acupuncture for Hormone Therapy-Related Side Effects in Breast Cancer Patients: A GRADE-Assessed Systematic Review and Updated Meta-Analysis. Integr Cancer Ther. 2020 Jan-Dec;19:1534735420940394.

Zhukovsky DS (2002)
Zhukovsky DS. Fever and sweats in the patient with advanced cancer. Hematol Oncol Clin North Am. 2002 Jun; 16(3): 579-88.